课题基金 / 基金详情

Probiotic bifidobacteria as a promising therapy to mitigate uremic toxin accumulation in chronic kidney disease

Probiotic bifidobacteria as a promising therapy to mitigate uremic toxin accumulation in chronic kidney disease
益生菌双歧杆菌是减轻慢性肾病尿毒症毒素积累的有前途的疗法
批准号：
449824
负责人：
Stuivenberg Gerrit A
金额：
$1.27万
依托单位：
University of Western Ontario
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449824&lang=en
关键词：
Host Health Host-Microbe Interactions Metabolism Microbiota Prebiotics Probiotics Renal Disease Therapeutic Assessment Toxicology Uremic Toxins

项目摘要

项目成果

Stuivenberg Gerrit A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The accumulation of uremic toxins in the blood of chronic kidney disease patients is a common occurrence and enhances the severity of the disease. Dialysis is the gold standard therapy to filter these toxins from the body. However, the procedure is ineffe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the role of gut microbiota derived uremic toxins in kidney stone disease.
  • 批准号：
    475904
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2022
  • 负责人：
    Stuivenberg Gerrit A
  • 依托单位：
    University of Western Ontario
海外基金